OK HB1344

Authorizes prescribers to issue prescriptions for off-label drugs (FDA-approved for one condition but prescribed for another) with informed consent from patient, parent/guardian, or health care power of attorney holder.

Permits pharmacists and hospitals/inpatient facilities to dispense off-label drugs unless they have moral, ethical, or religious objections, or documented life-threatening allergies or contraindications exist.

Provides immunity from administrative and civil liability for pharmacists, hospitals, and inpatient facilities that dispense off-label drugs in good faith and document their objective scientific basis for objections.

Allows outpatient physicians to apply for temporary privileges (approval within 5 days) at hospitals/inpatient facilities to prescribe off-label drugs for critically ill patients; permits patient-owned drugs to be brought into facilities and administered by alternative prescribers if in-house providers decline.

Prohibits health-related licensing boards from disciplining prescribers or pharmacists for actions under this law except for recklessness or gross negligence, and bars the World Health Organization from having jurisdiction over off-label prescribing in Oklahoma; effective November 1, 2025.